Sign in

CIK 0000879407

  • Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
460408024
Phone
+1 626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Grant or award Director acquired 25,000 shares (grant or award)
  2. 4 Grant or award Director acquired 30,000 shares (grant or award)
  3. 4 Grant or award Director acquired 35,000 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award Chief Operating Officer acquired 150,000 shares (grant or award)
  8. 4 Open-market sale Chief Financial Officer sold 23,347 shares at $6.13 ($143,117)
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 58,712 shares (to pay taxes)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Derivatives Options or other derivatives
  12. 4 Grant or award Chief Operating Officer acquired 150,000 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 360,000 shares (grant or award)
  14. 4 Grant or award CFO acquired 50,000 shares (grant or award)
  15. 4 Grant or award Director acquired 25,000 shares (grant or award)
  16. 4 Grant or award Director acquired 25,000 shares (grant or award)
  17. 4 Grant or award Director acquired 30,000 shares (grant or award)
  18. 4 Grant or award Director acquired 35,000 shares (grant or award)
  19. 4 Open-market buy Director bought 2,300 shares at an average $6.44 ($14,808)
  20. 4 Open-market sale Chief Scientific Officer sold 15,000 shares at $8.01 ($120,104)

Page 16 of 25 · 497 filings